Camden Cuts 'Did Not Attend' Rates with Integrated Care

EMISClinicians in north London are breaking down inter-professional barriers and reducing ‘did not attend’ (DNA) rates for patients with serious long term conditions. Their clinical commissioning group (CCG) is using data-sharing to integrate care across primary and secondary care, and help avoid hospital admissions. Subject to patient consent at the point of care, clinicians in Camden have a secure view of vital medical information held in GP records - using EMIS Web - in these key areas:
  • Community diabetes
  • Community chronic kidney disease
  • Community joint CKD/Diabetes
  • Community Geriatrician
  • Frailty MDT
  • Community heart failure
  • Community chronic obstructive pulmonary disease
  • Memory Service
  • improving access to psychological therapies (IAPT)

Using the system's search and reports facility, clinicians treating 1407 patients in the diabetes service have reduced the DNA rate from 26 per cent in 2012 to 10 per cent in 2013. It is also helping them to triage care more effectively.

Specialist diabetes nurse Vanessa Sawmynaden said: "Being able to view the GP record means I can check past consultations, history, results and information from hospital appointments - data that is frequently missing from referral letters. We can also track if a patient is seeing another diabetes team, for example in hospital. This enables us not only to prevent duplication of care, but also coordinate it more effectively."

Search and reports has also enabled managers to keep track of DNAs among 70 frail elderly patients. Operations manager Agnes Rieu said: "Patients had been used to going to the hospital, and now they are being seen in community clinics instead. Activity reports revealed where DNA rates were high and we realised there was a job to do in educating patients about accessing the new community-based service."

Clinicians say the data sharing technology is essential to help them manage their caseload and make better clinical decisions.

"EMIS Web Community has helped us break down barriers in our multidisciplinary meeting," said GP Dr Stuart Mackay-Thomas, the CCG's Frailty Lead. "Up to date medical notes from the GP means we are much better informed to make the right decisions about care for these vulnerable patients who have a range of complex needs. It is a stable and reliable platform."

Community teams are also using the technology to create care plans for patients which are then sent electronically to their GP, keeping them fully informed about specialist treatment outside the practice. Ms Rieu added: "EMIS Web has brought benefits for everyone: patients, clinicians & commissioners. It is so intuitive: just look at the screen and everything you need is there."

Related news articles:

About EMIS
EMIS is part of EMIS Group - the UK leader in connected healthcare software and services. EMIS systems hold over 40 million patient records and are used by nearly 6,000 healthcare organisations - from GP practices to community, child and mental health services. 53%* of GP practices in the UK use an EMIS system.

Founded by two forward-thinking GPs, EMIS helps clinicians share vital information, facilitating better, more efficient healthcare and supporting longer and healthier lives.

The company's flagship EMIS Web system enables secure shared access to a patient's whole-life electronic health record. It is the most widely-used GP clinical system in the UK.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...